Renew Life Women's Care Probiotic 90 Billion CFU
Acidophilus by Renew Life
- Price
- $38.00
- Servings
- 30
- Price/serv
- $1.27
Supplement Facts
Serving size: 1 Capsule(s) · 30 servings per container
| Ingredient | Amount per serving |
|---|---|
| Women's Complete Blend | 0 NP |
| Lactobacillus acidophilus | 0 NP |
| Lactobacillus plantarum | 0 NP |
| Lactobacillus salivarius | 0 NP |
| Lactobacillus casei | 0 NP |
| Lactobacillus gasseri | 0 NP |
| Lactobacillus paracasei | 0 NP |
| Lactobacillus rhamnosus | 0 NP |
| Total Lacto Probiotic Cultures | 0 NP |
| Bifidobacterium lactis | 0 NP |
| Bifidobacterium infantis | 0 NP |
| Bifidobacterium bifidum | 0 NP |
| Bifidobacterium longum | 0 NP |
| Total Bifido Probiotic Cultures | 0 NP |
| Total Bifido/Lacto Cultures | 0 NP |
Suggested use: Take 1 capsule daily, with or without food.
Other ingredients: Vegetable Capsule, Cellulose
What the brand says
Renew Life Women's Probiotic Capsules offers 12 probiotic strains to help maintain healthy vaginal bacteria and yeast levels, and support urinary, digestive and immune health (1). Featuring more clinically studied strains than the leading brand (2), these vaginal probiotics contain a blend of 12 different probiotic strains including L. rhamnosus GG, the No. 1 most studied strain (3). With 90 billion cultures, these Renew Life probiotic capsules make it easy for you to support your vaginal, urinary, digestive and immune health. Each strain is clinically tested and formulated by microbiologists and researchers to offer science-backed health benefits you can enjoy every day. Potency, quality and purity are guaranteed through the expiration date. This daily probiotic supplement offers a Non-GMO Project Verified formula that is gluten-free, dairy-free and soy-free. Renew Life puts health and wellness first with supplements that are backed by over 25 years of clinical trials. (1) These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. (2) Based on IRI unit sales data, January 2021. (3) L. rhamnosus GG strain, PubMed Clinical Trials, August 2019.